Abstract:Purpose/Objective(s) Nearly half of patients diagnosed with head and neck cancers are 65 years or older at the time of diagnosis. Older adults with cancer are at increased risk of treatment related toxicities and recent studies have suggested that geriatric assessment can be used to predict those at risk of excess toxicities. The objective of the current study was to study the prevalence of frailty and geriatric assessment impairments among older adults diagnosed with head and neck cancers. Materials/Methods Using data from the Cancer and Aging Resilience Evaluation (CARE) registry, a prospective cohort study of older adults (≥60y) diagnosed with cancer, we identified patients with biopsy proven head and neck cancers with an initial medical oncology visit at our institution between 3/2018 and 5/2021. All patients underwent a pragmatic multidimensional GA prior to their initial oncologist visit, as previously described (Williams et al J Geriatr Oncol 2019). Using deficit accumulation method, we constructed a 44-item frailty index (CARE-FI), categorizing patients as robust, pre-frail, and frail. Domain specific impairments were characterized using published cut points. Subsequently, we examined the prevalence of frailty and GA domain impairments and the association between pre-treatment frailty and overall survival in multivariable time to event (Cox) models adjusted for age, sex, race/ethnicity, cancer stage and time from diagnosis. All statistical tests were two sided and the level of significance was chosen as 0.05. Results A total of 94 patients were identified with a mean age of 70±7y, 79% males and 87% non-Hispanic Whites. Majority of patients had stage III (20%) or IV cancers (52%; 27% with distant metastasis) treated with radiation therapy (76%), chemotherapy (64%) and/or surgery (46%). Overall, 23% and 30% respectively were identified as pre-frail or frail respectively. GA impairments were prevalent: 19% reported ≥1 falls in past 6 months, 17% reported dependence in activities of daily living (ADL), 53% reported dependence in Instrumental ADL, 43% had malnutrition, 72% reported polypharmacy (≥4 medications) and 40% had ≥3 comorbidities. As compared to robust patients, frailty was associated with significantly increased risk of all-cause mortality in unadjusted (HR 2.74; 95% CI 1.19-6.35; p=0.02) and adjusted (HR 2.37; 1.03-6.08; p=0.04) models. Conclusion Frailty and GA impairments are common among older adults with head and neck cancers and appear to have prognostic relevance. Future studies should explore how GA can inform treatment decision making and guide interventions to improve treatment outcomes in this population.

Treatment of elderly patients with head and neck cancer in an aging society: Focus on geriatric assessment and surgical treatment

Head and Neck Cancer and the Elderly Patient

Management of breast cancer in older patients

Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland

Head and Neck Cancer Surgery in the Elderly

Incidence and risk factors for morbidity and mortality in elderly head and neck cancer patients undergoing major oncological surgery

Treatment of Elderly Patients with Colorectal Cancer

Descriptive epidemiology of the head and neck cancers in old patients

Postoperative Radiochemotherapy Using Modern Radiotherapy Techniques in Elderly Patients with Head and Neck Squamous Cell Carcinoma: The Challenge of Weighing Up Benefits and Harms of Treatment Modalities in Clinical Practice

Patterns of cancer treatment in different age groups in Japan: an analysis of hospital-based cancer registry data, 2012–2015

Treatment strategies for patients over 80 years of age with oral squamous cell carcinoma

Management of Nasopharyngeal Carcinoma in Elderly Patients

Geriatric oncology: comparing health related quality of life in head and neck cancer patients

Prevalence and Impact of Frailty and Geriatric Assessment Identified Impairments among Older adults diagnosed with head and neck cancers

Adjuvant chemoradiotherapy in elderly patients with head and neck cancer: a monoinstitutional, two-to-one pair-matching analysis

Efficacy of Chemoradiotherapy in Elderly Patients with Stage IV Inoperable Head and Neck Cancer

Factors to consider for surgical in elderly patients with oral cancer

Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis

Narrative review of immunotherapy and radiation therapy in elderly patients

Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis

Updates on the Management of Colorectal Cancer in Older Adults